Loading company…
Nervonik develops neuromodulation implants for chronic neuropathic pain.
Nervonik develops peripheral nerve stimulation implants designed to modulate nerve activity and treat chronic neuropathic pain. Founded by CEO Aydin Babakhani and based in Los Angeles, the company raised USD 52.5 million in Series B funding in April 2026, co-led by Sofinnova Partners and Amzak Capital Management, with Elevage Medical Technologies, LP, Lumira Ventures, ShangBay Capital, Foothill Ventures, US Venture Partners and other investors participating. Funding will support system development, sensing capabilities, clinical programs and commercialization preparation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in